SCNI   $4.0  7.82% Market Open

Scinai Immunotherapeutics Ltd
Total Cash 3.08M
totalCashPerShare 0.001
EBITDA -7.00M
Total Debt 20.82M
quickRatio 1.911
currentRatio 2.187
Total Revenue 284.00K
debtToEquity
Revenue/Share 0.555
ROA -0.28347
ROE
grossProfits
freeCashflow -3.79M
operatingCashflow -6.67M
earningsGrowth
revenueGrowth
grossMargins -0.57746
ebitdaMargins 0.0
operatingMargins -7.13732
profitMargins 0.0
enterpriseValue 12.14B
forwardPE
floatShares 2.92B
sharesOutstanding 837.31K
sharesShort 20.18K
sharesShortPriorMonth 10.07K
dateShortInterest
sharesPercentSharesOut 0.02%
heldPercentInsiders 0.13%
heldPercentInstitutions 0.05%
Short Ratio help_outline 0.38%
shortPercentOfFloat 0.11%
impliedSharesOutstanding
bookValue -8.699
Price To Book help_outline
earningsQuarterlyGrowth
netIncomeToCommon -3.70M
trailingEps 0.0
forwardEps
enterpriseToEbitda -1.73K
lastDividendValue
lastDividendDate
currentQuarterEstimate 1Q 2024
institutionsCount 13
lastUpdated Oct. 17, 2024, 12:34 p.m.